Statistics for The prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease
Total visits
views | |
---|---|
The prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease | 1 |
Total visits per month
views | |
---|---|
October 2023 | 0 |
November 2023 | 0 |
December 2023 | 0 |
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
File Visits
views | |
---|---|
ucalgary_2008_supina_alison lorraine_559982.pdf | 10 |
Top country views
views | |
---|---|
Canada | 1 |
Top city views
views | |
---|---|
Calgary | 1 |